# PR #11 Prep Report

## Summary
- **PR:** #11
- **Worktree:** `/home/ubuntu/worktrees/portfolio-optimizer-oos`
- **Head:** `0283cb3` — "Refactor portfolio optimizer OOS weight persistence and covariance handling"
- **Base:** `codex/new-main`
- **Branch state touched by prep:** none
- **Changed files vs base:** `runner/portfolio_optimizer.py` (37 insertions, 28 deletions)

## What I did
1. Inspected the PR diff and worktree status (clean, no uncommitted mutations).
2. Ran targeted offline tests covering the changed behavior:
   - `pytest tests/test_portfolio_optimizer_oos.py -q` → 26 passed
   - `pytest tests/test_risk_parity_optimizer.py -q` → 3 passed
3. Verified branch immutability: no commits, pushes, merges, rebases, or protected artifact changes.
4. Attempted local SonarScanner; not installed in this environment. Used offline alternatives instead.
5. Checked whitespace/diff hygiene: `git diff --check` clean.
6. Confirmed the changed module compiles and imports cleanly.

## Test Results

| Scope | Command | Result |
|------|---------|--------|
| Focused OOS optimizer tests | `pytest tests/test_portfolio_optimizer_oos.py -q` | 26 passed |
| Adjacent risk parity tests | `pytest tests/test_risk_parity_optimizer.py -q` | 3 passed |
| Module compile/import | `python -m py_compile runner/portfolio_optimizer.py` + import | PASS |
| Diff whitespace check | `git diff --check origin/codex/new-main..HEAD` | PASS |
| Full repo test suite | `pytest tests/` | Blocked by missing runtime deps (`sentry_sdk`) unrelated to PR |

## Observed Behavior Changes (from diff)
1. **Weight normalization safety**
   - Introduced `_normalize_weights()` to replace inline sum-and-divide logic.
   - Prevents `nan`/`inf` when Optuna draws all-zero weights during trials.
   - Falls back to equal-weight instead of pruning or crashing.

2. **Equity-curve alignment correction**
   - Restricts `_align_equity_curves(..., require_overlap=False)` to the **common covered window** (`window_start … window_end`), not the global union.
   - Eliminates synthetic pre-inception flat equity values and post-end extrapolation.
   - Seeds forward-fill from a real value at or before the common window (`prior_times`).

## Quality-Gate Evidence
- **SonarScanner:** Not available on this runner. No auth issue; tool is missing. If Sonar is required, install locally or rely on CI.
- **Lint/type-check proxy:**
  - `py_compile` clean.
  - Import of `runner.portfolio_optimizer` and `runner.risk_parity_optimizer` clean.
  - Ruff is configured in `pyproject.toml` but is not installed in the active venv. I cannot install it due to environment pip restrictions; ensure `ruff` runs in CI/dev if lint gates exist.

## Findings / Blockers
- **No blocking test failures** in the targeted scope.
- **Minor environment blocker:** Some repository test files (`tests/test_optimizer.py`) import `sentry_sdk`, which is not installed locally. This blocks running the entire repo suite offline, but it is **unrelated to PR #11** because the head commit touches only portfolio optimizer/OOS alignment and weight handling.
- **Likely fix / remediation steps:**
  1. Merge PR #11 after confirming the targeted green tests above.
  2. Ensure CI enforces `require_overlap=True` wherever absolute alignment safety is required; the default behavior here is now safer but still uses forward-fill inside the common window.
  3. Add `_align_equity_curves(require_overlap=True)` to any callers that need exact intersection, especially if future callers assume a strict overlap.
  4. Add a regression test for `require_overlap=True` with a single late-start strategy to guard against contraction over time.
  5. Ensure `ruff` and type-checking are installed/run in the quality pipeline (the change is small enough that manual review suggests no new issues).

## Evidence Artifacts
- `/home/ubuntu/worktrees/portfolio-optimizer-oos/runner/portfolio_optimizer.py` — modified source
- `/home/ubuntu/worktrees/portfolio-optimizer-oos/tests/test_portfolio_optimizer_oos.py` — focused tests
- `/home/ubuntu/review-artifacts/pr11-prep/report.md` — this report
